United Kingdom: King Charles diagnosed with cancer, Buckingham Palace announces

Date:

No news on the type of cancer but according to a palace statement the King began “regular treatments” this Monday. Buckingham Palace says King Charles “is optimistic about his treatment and looks forward to returning to fully carrying out his public duties”

Tumor diagnosis for King Charles III, 75, who, as revealed by Buckingham Palace, began treatment today.

The news comes just over a week after treatment for an enlarged prostate: the British sovereign was discharged on Monday 29 January from the London Clinic after surgery the previous Friday for a benign prostate condition. After three nights spent in hospital, he returned to his residence, accompanied by Queen Consort Camilla.

Buckingham Palace clarified that the cancer is not in the prostate, but was diagnosed following the operation he underwent last month.

Rishi Sunak’s message to King Charles

Sunak: I wish His Majesty a speedy and full recovery
“I wish His Majesty a speedy and complete recovery. I have no doubt that he will be back to strength in no time and I know that the whole country wishes him the best,” British Prime Minister Rishi Sunak wrote on X. Closeness to the sovereign for a speedy recovery also came from the opposition leader, Labor Party Keir Starmer, and from the heads of the governments of Scotland, Wales and Northern Ireland.

This article is originally published on it.euronews.com

Share post:

Subscribe

Electric Scooter XElectric Scooter X

Popular

More like this
Related

US Military Overstretch Raises Strategic Opportunity for Europe’s Defence and Security

The growing demands on the United States military across...

Iran Begins Days-Long Funeral for Supreme Leader Ali Khamenei After Wartime Death

Iran has begun a days-long state funeral for the...

Next Eyes Harvey Nichols Takeover as Luxury Retail Sale Process Accelerates

British fashion retailer Next is preparing a takeover bid...

European Shares Slide as Iran Peace Hopes Fade and Markets React

European shares dipped as renewed uncertainty over the prospects...